Experimental Coronavirus Drug remdesivir being applied for Patent by China
Experimental Coronavirus Drug Remdesivir Being Applied For Patent By China:



Remdesivir Was Developed By Gilead Sciences As A Treatment For Ebola Virus Disease And Marburg Virus Infections. It Is Found To Be Effective On Distantly Related Viruses Such As Respiratory Syncytial Virus, Junin Virus, Lassa Fever Virus, And MERS-coronavirus.



The Wuhan Institute Of China In Its Statement Said That It Made The Patent Application Out Of National Interest, And Won’t Exercise Its Patent Rights If Foreign Pharmaceutical Firms Work Together With China To Curb The Contagion.

New Videos / Images

Related Tags

Send Quote To Your Friend